Dr. David Spigel: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?
May 11, 2013•4 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. David Spigel, Sarah Cannon Cancer Center, offers his insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more multifocal progression after a good initial response to a targeted agent.
For the best experience, listen in Metacast app for iOS or Android